Conning Inc’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-372
| Closed | -$209K | – | 333 |
|
|
2026
Q1 | $209K | Sell |
372
-41
| -10% | -$26.3K | 0.01% | 302 |
|
|
2025
Q4 | $279K | Buy |
413
+15
| +4% | +$10.2K | 0.01% | 296 |
|
|
2025
Q3 | $254K | Hold |
398
| – | – | 0.01% | 315 |
|
|
2025
Q2 | $213K | Buy |
+398
| New | +$190K | 0.01% | 331 |
|
|
2024
Q4 | – | Sell |
-516
| Closed | -$261K | – | 356 |
|
|
2024
Q3 | $261K | Sell |
516
-8
| -2% | -$3.89K | 0.01% | 316 |
|
|
2024
Q2 | $255K | Buy |
524
+13
| +3% | +$6.53K | 0.01% | 311 |
|
|
2024
Q1 | $276K | Hold |
511
| – | – | 0.01% | 305 |
|
|
2023
Q4 | $284K | Buy |
511
+10
| +2% | +$4.7K | 0.01% | 293 |
|
|
2023
Q3 | $219K | Sell |
501
-12
| -2% | -$5.98K | 0.01% | 313 |
|
|
2023
Q2 | $258K | Sell |
513
-85
| -14% | -$40.7K | 0.01% | 310 |
|
|
2023
Q1 | $299K | Sell |
598
-6
| -1% | -$2.87K | 0.01% | 296 |
|
|
2022
Q4 | $246K | Buy |
+604
| New | +$234K | 0.01% | 335 |
|
|
2022
Q3 | – | Sell |
-646
| Closed | -$227K | – | 379 |
|
|
2022
Q2 | $227K | Sell |
646
-2
| -0.3% | -$816 | 0.01% | 369 |
|
|
2022
Q1 | $354K | Sell |
648
-52
| -7% | -$27.4K | 0.01% | 315 |
|
|
2021
Q4 | $461K | Sell |
700
-972
| -58% | -$610K | 0.01% | 270 |
|
|
2021
Q3 | $1.04M | Buy |
1,672
+700
| +72% | +$470K | 0.03% | 190 |
|
|
2021
Q2 | $614K | Sell |
972
-120
| -11% | -$66.3K | 0.02% | 250 |
|
|
2021
Q1 | $534K | Sell |
1,092
-101
| -8% | -$50.6K | 0.02% | 263 |
|
|
2020
Q4 | $596K | Sell |
1,193
-35
| -3% | -$15.7K | 0.02% | 253 |
|
|
2020
Q3 | $483K | Buy |
1,228
+25
| +2% | +$9.24K | 0.02% | 273 |
|
|
2020
Q2 | $397K | Sell |
1,203
-61
| -5% | -$17.7K | 0.01% | 292 |
|
|
2020
Q1 | $306K | Sell |
1,264
-96
| -7% | -$25.1K | 0.01% | 314 |
|
|
2019
Q4 | $355K | Buy |
1,360
+180
| +15% | +$47.4K | 0.01% | 352 |
|
|
2019
Q3 | $321K | Buy |
1,180
+30
| +3% | +$8.35K | 0.01% | 385 |
|
|
2019
Q2 | $317K | Sell |
1,150
-320
| -22% | -$78.8K | 0.01% | 391 |
|
|
2019
Q1 | $329K | Buy |
1,470
+100
| +7% | +$20.6K | 0.01% | 420 |
|
|
2018
Q4 | $255K | Sell |
1,370
-60
| -4% | -$12.3K | 0.01% | 445 |
|
|
2018
Q3 | $357K | Sell |
1,430
-50
| -3% | -$12.1K | 0.01% | 449 |
|
|
2018
Q2 | $323K | Sell |
1,480
-20
| -1% | -$4.12K | 0.01% | 473 |
|
|
2018
Q1 | $287K | Sell |
1,500
-50
| -3% | -$9.23K | 0.01% | 500 |
|
|
2017
Q4 | $242K | Buy |
+1,550
| New | +$244K | 0.01% | 544 |
|
Other funds holding IDXX
Conning Inc's IDXX Position: Q2 2026 in Review
Conning Inc sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 372 shares — an estimated $209K sold.
Conning Inc first reported a position in IDXX in Q4 2017 and held it in 31 quarters. The position peaked at $1.04M in Q3 2021. 1,305 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Conning Inc reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
- Conning Inc sold 372 Idexx Laboratories shares in Q2 2026, an estimated $209K.
- Conning Inc first reported a position in Idexx Laboratories in Q4 2017 and held it in 31 quarters.
- Conning Inc's Idexx Laboratories position peaked at $1.04M in Q3 2021.
- 1,305 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Conning Inc's 13F filing for Q2 2026, filed 30 Jul 2026.